T3 Pharma, a biotech start-up company of the University of Basel with a focus on immuno-oncology, has been named “2018 Science Start-Up of the Year” by Falling Walls Venture. The award honors the scientist-entrepreneurs for their breakthrough business model in bacterial cancer therapy.
The Falling W...
Original Article: T3 Pharmaceuticals wins prestigious Falling Walls Venture Award